STRIDES PHARMA INTL secured FDA approval for its generic product via ANDA075295, a regulatory milestone expected to bolster its portfolio and generate...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
# FDA Approves Janssen Pharmaceuticals' TOPAMAX (Topiramate) for Oral Use Janssen Pharmaceuticals, Inc. received FDA approval for TOPAMAX (topiramate...
Genentech, Inc. announced the approval of CELLCEPT (mycophenolate mofetil) oral suspension, providing clinicians with a critical liquid formulation to...
# FDA Approves Fresenius Kabi's Intravenous Fluorouracil Formulation Fresenius Kabi USA, LLC received FDA approval for its intravenous fluorouracil f...
# FDA Approves Genentech's Herceptin for HER2-Positive Breast Cancer Genentech's HERCEPTIN (trastuzumab), the first monoclonal antibody approved for ...
Amneal Pharmaceuticals’ recent FDA approval for the generic version of butalbital/aspirin/caffeine/codeine phosphate positions the company to capture ...
Genentech's (NYSE: DNA) CELLCEPT received FDA approval on August 12, 1998, for the intravenous formulation of mycophenolate mofetil hydrochloride, an ...
# FDA Approves NorthStar Rx LLC's Labetalol Hydrochloride for Oral Administration NorthStar Rx LLC has received FDA approval for its generic labetalo...
HIKMA Pharmaceuticals has announced the approval of an Abbreviated New Drug Application (ANDA) by the U.S. Food and Drug Administration, signaling fir...
SUN PHARM INDUSTRIES announced FDA approval for ANDA040260, securing a regulatory milestone that adds a new generic option to its portfolio and positi...
Celgene Corporation rallied on July 16, 1998, following the FDA's approval of its oral Thalomid (thalidomide) therapy, marking a pivotal moment for th...
Rhodes Pharmaceuticals announced the FDA approval of its Morphine Sulfate Extended Release tablets, adding a high-volume product to its generic portfo...
Rhodes Pharmaceuticals LLC obtained FDA clearance to market Morphine Sulfate Extended Release, a generic entry poised to capture market share from the...
VistaPharm, LLC has earned regulatory approval to manufacture and market its ANDA for the generic version of methadone hydrochloride, a move poised to...
# FDA Approves Progesterone Oral Formulation for Acertis Pharmaceuticals Acertis Pharmaceuticals, LLC has received FDA approval for PROMETRIUM (proge...
# FDA Approves Allergan's ACTONEL (Risedronate Sodium) for Oral Administration Allergan, Inc. has received FDA approval for ACTONEL (risedronate sodi...
ANI PHARMS has announced the successful approval of its ANDA filing, enabling the company to capitalize on forecasted market opportunities in the gene...
Excedrin Migraine GelTabs has been approved by the U.S. Food and Drug Administration, with Haleon US Holdings LLC now overseeing the oral acetaminophh...
# FDA Approves Cumberland Pharmaceuticals' KRISTALOSE (Lactulose) for Oral Administration Cumberland Pharmaceuticals Inc. received FDA approval for K...
# Sandoz Receives FDA Approval for Generic Drug Sandoz has received FDA approval for a generic drug formulation under ANDA040194, expanding the compa...